The Patent Finder

Terms ending in 2031

GlaxoSmithKline LLC

Every in-force patent on GlaxoSmithKline LLC's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US D775,945Package
In force
 · High confidence
Haleon UK IP LimitedIn forceHigh confidence
US 8,410,103(3S,11aR)-N-[2,4-Difluorophenyl)METHYL]-6-Hydroxy-3-Methyl-5,7-Dioxo-2,3,5,7,11,11a-HEXAHYDRO[1,3]OXAZOLO[3,2-a]PYRIDO[1,2-d]PYRAZINE-8-Carboxamide USEFUL AS ANTI-HIV AGENT
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 8,273,782Inhibitors of Akt Activity
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 9,023,842Benzodiazepine Bromodomain Inhibitor
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 9,102,677Benzodiazepine Bromodomain Inhibitor
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 8,887,659Continuous Coating of Pellets
Grace period ended Nov 18, 2026 · lapse expected
 · Low confidence
GlaxoSmithKline LLCGrace period ended Nov 18, 2026
lapse expected
Low confidence
US 8,609,711Crystalline N-{(1S)-2-Amino-1-[(3-Fluorophenyl)METHYL]ETHYL}-5-Chloro-4-(4-Chloro-1-Methyl-1H-PYRAZOL-5-YL)-2-Thiophenecarboxamide Hydrochloride
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 9,360,482Process for the Identification of a Compound Which Inhibits the Binding of the Second Bromodomain of Each of Human BRD-2, BRD-3, and BRD-4
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 9,062,003Benzimidazole Derivatives as PI3 Kinase Inhibitors
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 9,156,797Benzimidazole Derivatives As PI3 Kinase Inhibitors
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
3 more term ends in 2031 · Pro
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
Upgrade to Pro
10 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited